Skip to content

Coronary Microvascular Disease Assessment via Coronary Computed Tomography Angiography Derived index IMRCT: A Nationwide Multicenter Prospective Study(MAPS Trial)

Coronary Microvascular Disease Assessment via Coronary Computed Tomography Angiography Derived index IMRCT: A Nationwide Multicenter Prospective Study(MAPS Trial)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090722
Enrollment
Unknown
Registered
2024-10-12
Start date
2024-12-12
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary microvascular disease, CMD

Interventions

Gold Standard:Index of Microcirculatory Resistance,IMR. People with IMR=25 will be diagnosed as CMD.
Index test:IMRct was the first parameter to be named for the original computational model constructed by our research group and the team from Sun Yat-sen University. The definiton of IMRct is a estima

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >=18 years old; 2. For suspected coronary atherosclerotic heart disease, CCTA was performed within 1 month before admission. Completed intracavitary functional examination (FFR, IMR, CFR) during the hospitalization; 3. Be able to understand the purpose of this study and sign the informed consent; 4. Be able to comply with all research requirements; 5. CCTA image data is required by standardized image acquisition and reconstruction Settings, and the image quality is good, meeting the analysis requirments; 6. The stenosis of subepicardial great vessel is 30% to 90% or coronary contrast agent retention or TIMI is grade 2. 7. The data of coronary angiography and intracavitary functional indexes (FFR, IMR, CFR) were completed.

Exclusion criteria

Exclusion criteria: 1. Acute myocardial infarction; 2. Stenosis of left main coronary artery >=50%; 3. Previous PCI or CABG; 4. Chronic complete occlusive disease of coronary artery; 5. Hypertrophic cardiomyopathy (both obstructive and non-obstructive); 6. Severe obstructive heart disease, such as moderate to severe aortic stenosis, mitral stenosis, etc; 7.Tako Tsubo Syndrome (TTS); 8. Arrhythmias affect image analysis, such as atrial fibrillation and frequent ventricular premature; 9. Life expectancy 400; 12. Myocardial bridge compression of more than 70%; 13. Other situations that are not suitable for inclusion in this study.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;

Countries

China

Contacts

Public ContactZhihui Zhang

The First Affiliated Hospital of Army Medical University

xyzpj@126.com+86 23 68765261

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026